Esketamine, a Treatment for Depression, Receives FDA Approval

The nasal spray to ease intractable depression appears on the US market after decades without novel antidepressant treatments.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news
More News: Depression | Science